{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:57:57Z","timestamp":1793642277865,"version":"4.5.1"},"reference-count":10,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:p>Most people with episodic tension-type headache (TTH) treat themselves with over-the-counter analgesics. In the absence of clear evidence of dose-related efficacy of the two most commonly used analgesics, aspirin (acetylsalicylic acid) and paracetamol (acetaminophen), this study compared two doses of each with placebo. In a double-blind, double-dummy, randomized parallel-groups comparative trial, 638 consenting subjects aged 16-65 years with episodic TTH (but not migraine) by IHS criteria were recruited from the UK general population by advertisement. They treated one episode of moderate or severe TTH with a single dose of 500 or 1000 mg aspirin, 500 or 1000 mg paracetamol or placebo. The primary objective was to compare aspirin 1000 mg with placebo, and the primary end-point was subjective pain relief (total or worthwhile) 2 h after treatment ('response'). Additionally, pain intensity on a 100-mm visual analogue scale and functional impairment were monitored regularly for 4 h and at 24 h, although rescue medication was allowed after 2 h. The analysis was of the intention-to-treat population of 542 who took treatment (all providing outcome data). Treatment groups were matched at baseline. Aspirin 1000 mg (75.7% response rate; P = 0.0009) and to a lesser extent aspirin 500 mg (70.3%; P = 0.011) and paracetamol 1000 mg (71.2%; P = 0.007), but not paracetamol 500 mg (63.8%; P = 0.104), were statistically more effective than placebo despite a high placebo-response rate (54.5%). Outcome was not affected by headache intensity at baseline. Secondary end-points including functional recovery (by median times of 4.0-13.5 h) were consistent with these findings, although a minority of subjects recorded long-duration functional impairment (37-54 h). Adverse events reported by 13.4-18.9% of subjects were mild or moderate, and transient. No safety concerns arose.<\/jats:p>","DOI":"10.1046\/j.1468-2982.2003.00470.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:12:53Z","timestamp":1047366773000},"page":"59-66","source":"Crossref","is-referenced-by-count":106,"title":["Aspirin in Episodic Tension-Type Headache: Placebo-Controlled Dose-Ranging Comparison with Paracetamol"],"prefix":"10.1177","volume":"23","author":[{"given":"TJ","family":"Steiner","sequence":"first","affiliation":[{"name":"Division of Neuroscience, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lange","sequence":"additional","affiliation":[{"name":"Bayer AG, BG Consumer Care, Leverkusen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Voelker","sequence":"additional","affiliation":[{"name":"Bayer AG, BG Consumer Care, Leverkusen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2003,2,1]]},"reference":[{"key":"bibr1-j.1468-2982.2003.00470.x","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-2982.1988.0801001.x","volume":"8","author":"Headache Classification Committee of the International Headache Society.","year":"1988","journal-title":"Cephalalgia"},{"key":"bibr2-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.1046\/j.0333-1024.2001.00251.x"},{"key":"bibr3-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.1002\/cpt19645121"},{"key":"bibr4-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90526-0"},{"key":"bibr5-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1987.hed2702090.x"},{"key":"bibr6-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2001.00216.x"},{"key":"bibr7-j.1468-2982.2003.00470.x","first-page":"40","volume":"2","author":"MacEachern L","year":"2001","journal-title":"J Pain"},{"key":"bibr8-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199918020-00001"},{"key":"bibr9-j.1468-2982.2003.00470.x","doi-asserted-by":"publisher","DOI":"10.1159\/000116818"},{"key":"bibr10-j.1468-2982.2003.00470.x","unstructured":"British Association for the Study of Headache. (2001 ) Guidelines for All Doctors in the Diagnosis and Management of Migraine and Tension-Type Headache [WWW document]. BASH URL http:\/\/www.bash.org.uk."}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1046\/j.1468-2982.2003.00470.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1046\/j.1468-2982.2003.00470.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1046\/j.1468-2982.2003.00470.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:41:57Z","timestamp":1777387317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1046\/j.1468-2982.2003.00470.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1046\/j.1468-2982.2003.00470.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00470.x","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}